#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA683884	F	In vitro relative potency to morphine (IC50, 4.4E-8M) in mouse vas deferens was determined; inactive (potentiates contraction at >/=1.6E-6M)		1		tissue-based format	Scientific Literature
2.	ALA700603	F	Evaluated in vivo for the antinociceptive and opioid antagonist assays in ICR male mice, Tail-Flick agonist and antagonist tests was performed		7		organism-based format	Scientific Literature
3.	ALA700604	F	Evaluated in vivo for the antinociceptive and opioid antagonist assays in ICR male mice, Tail-Flick agonist and antagonist tests was performed; IA, Inactive less than 70% of mice affected at 30 mg/kg.		6		organism-based format	Scientific Literature
4.	ALA731688	F	Analgesic Potency in mice	Mus musculus	6		assay format	Scientific Literature
5.	ALA878521	F	Compound was tested for agonistic activity against the opioid receptor in electrically stimulated mouse vas deference	Mus musculus	4		assay format	Scientific Literature
6.	ALA739438	F	Compound was tested for agonistic activity against the opioid receptor in electrically stimulated mouse vas deference.	Mus musculus	1		assay format	Scientific Literature
7.	ALA741430	F	In vivo antinociceptive activity was determined upon subcutaneous administration by hot plate assay	Mus musculus	10		organism-based format	Scientific Literature
8.	ALA741432	F	In vivo antinociceptive activity was determined upon subcutaneous administration in the mouse paraphenylquinone writhing test; Inconsistent dose response.	Mus musculus	2		organism-based format	Scientific Literature
9.	ALA840877	F	Analgesic Potency was tested against mice		53		assay format	Scientific Literature
10.	ALA744347	B	Concentration required to inhibit the specific binding of tritiated ligand [3H]DADL to opiate receptor by 50%		3		protein format	Scientific Literature
11.	ALA744348	B	Concentration required to inhibit the specific binding of tritiated ligand [3H]naloxone to opiate receptor by 50%		1		protein format	Scientific Literature
12.	ALA748048	B	Tested for displacement of radioligand [3H]-Naloxone from opiate receptor		18		protein format	Scientific Literature
13.	ALA748049	B	Tested for displacement of radioligand [3H]naloxone from opiate receptor; ND, no data		1		protein format	Scientific Literature
14.	ALA748050	B	Tested for displacement of radioligand [3H]-Naloxone from opiate receptor; value ranges from 7-10 uM		1		protein format	Scientific Literature
15.	ALA749838	B	Concentration required to inhibit the specific binding of tritiated ligand [3H]-naloxone to opiate receptor by 50%	Mus musculus	1		protein format	Scientific Literature
16.	ALA754081	B	Compound was tested for binding affinity on intact HEK cells using [3H]diprenorphine as radioligand co-expressed with delta and kappa opioid receptor	Mus musculus	2		cell-based format	Scientific Literature
17.	ALA754082	B	Compound was tested for binding affinity on intact HEK cells using [3H]diprenorphine as radioligand co-expressed with delta and kappa opioid receptors	Mus musculus	5		cell-based format	Scientific Literature
18.	ALA754083	B	Compound was tested for binding affinity on intact HEK cells using [3H]diprenorphine as radioligand singly expressed with delta or kappa receptor	Mus musculus	4		cell-based format	Scientific Literature
19.	ALA883563	B	Compound was tested for binding affinity on intact HEK cells using [3H]diprenorphine as radioligand singly expressed with delta or kappa receptors.	Mus musculus	3		cell-based format	Scientific Literature
20.	ALA752108	F	Compound was tested for irreversible antagonist activity against opioid receptor in mouse vas deferens expressed as IC20 of morphine divided by the compound		2		tissue-based format	Scientific Literature